HER2 Neu Breast Cancer Test: Comprehensive FISH Analysis
Understanding HER2 Neu Testing for Breast Cancer
The HER2 Neu Breast Cancer Test represents a critical advancement in personalized cancer care, providing essential information about the genetic characteristics of breast cancer cells. This specialized diagnostic evaluation helps determine whether a patient’s breast cancer is HER2-positive, a finding that significantly influences treatment decisions and prognosis.
What Does the HER2 Neu Test Measure?
This sophisticated test specifically detects and quantifies HER2 (Human Epidermal Growth Factor Receptor 2) gene amplification in breast cancer tissue samples. Using FISH (Fluorescence In Situ Hybridization) methodology, the test examines:
- HER2 gene copy number in tumor cells
- Gene amplification status relative to chromosome 17
- Presence of HER2 protein overexpression
- Genetic markers for targeted therapy eligibility
Who Should Consider HER2 Neu Testing?
This test is particularly important for individuals experiencing or diagnosed with:
- Newly diagnosed invasive breast cancer
- Recurrent or metastatic breast cancer
- Aggressive tumor characteristics or rapid growth
- Family history of HER2-positive breast cancer
- Consideration for targeted therapy options
- Uncertain HER2 status from previous testing
Clinical Indications and Symptoms
Patients presenting with breast lumps, abnormal mammogram findings, or those undergoing breast cancer diagnosis should discuss HER2 testing with their healthcare provider. Early determination of HER2 status enables timely intervention with appropriate targeted treatments.
Benefits of HER2 Neu Testing
Undergoing HER2 Neu testing provides numerous advantages for breast cancer management:
- Personalized Treatment Planning: Determines eligibility for HER2-targeted therapies like trastuzumab (Herceptin)
- Prognostic Information: HER2 status provides valuable insights into disease aggressiveness
- Therapeutic Guidance: Helps oncologists select the most effective treatment regimen
- Monitoring Response: Establishes baseline for treatment effectiveness assessment
- Clinical Trial Eligibility: May qualify patients for novel HER2-targeted clinical trials
Understanding Your Test Results
HER2 Neu test results are typically categorized as:
- HER2-Positive: Indicates gene amplification, making targeted therapies highly effective
- HER2-Negative: No gene amplification detected; alternative treatment approaches recommended
- Equivocal: Requires additional testing or alternative methodology for confirmation
Your healthcare provider will interpret results in the context of your specific clinical situation and discuss appropriate next steps for your breast cancer treatment journey.
Test Information and Pricing
| Test Component | Details |
|---|---|
| Test Name | HER2 Neu Breast Cancer Test |
| Discount Price | $300 USD |
| Regular Price | $400 USD |
| Turnaround Time | 7-8 days |
| Sample Type | Tumor tissue (Paraffin embedded tissue blocks) |
| Testing Method | FISH (Fluorescence In Situ Hybridization) |
Pre-Test Instructions
The HER2 Neu Breast Cancer Test requires a Doctor’s prescription. Please note that prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad. Ensure you have your physician’s referral and relevant medical documentation when scheduling your test.
Nationwide Testing Availability
We have diagnostic branches conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities nationwide.
Take Control of Your Breast Cancer Journey
Don’t leave your treatment decisions to chance. Accurate HER2 status determination is crucial for effective breast cancer management. Our state-of-the-art FISH testing provides reliable results that can significantly impact your treatment outcomes.
Ready to schedule your HER2 Neu Breast Cancer Test? Call our dedicated patient care team today at +1(267) 388-9828 or book your appointment online. Our genetic specialists are available to answer your questions and guide you through the testing process.
Take the first step toward personalized breast cancer care with comprehensive HER2 Neu testing from General Genetics Corporation – your partner in advanced cancer diagnostics.
